(Testimony from Forbidden Health book)
Testimonial Dr. Camino. G. (MD) ACCREDITED CERTIFICATION OF HEALTH STATUS CERTIFIES That Ms. MIRIAM F.G., age 20, was diagnosed with cystic fibrosis and bronchopulmonary aspergillosis in 2000 and has been treated with oral antibiotic therapy and 6 IVs, in repeated cycles, according to sputum cultures. She went through three embolizations (2010, 2011 and 2013) for recurrent hemoptysis. This practice severely limited respiratory treatments, even though she was sensitive to tobramycin and colistin. In November 2012, the first resistance to antibiotics appeared “in vitro,” although “in vivo” she still responded to higher than usual doses, with TMP/ SMX (Trimethoprim-Sulfamethoxazole). In May 2013, once apparent the lack of effectiveness of Stenotrophomona maltophilia, we decide to intensify respiratory physiotherapy up to four daily sessions, to improve the patient’s quality of life (getting rest at night and aiding her university activities). On the same date, we initiated treatment with Aspergillus fumigatus with Itraconazole and corticotherapy, continuing it until the end of July 2013, with no results. Sputum cultures show sensitivity to Voriconazole, but we did not prescribe it due to the visible side effects produced years ago. The family decides to start treatment with MMS on August 17th, 2013. The treatment causes a significant reduction of bronchial secretions, allowing her to sleep at night and reduce to 1–2 the number of respiratory physiotherapy sessions. The patient improved significantly and recovered the lifestyle typical of her age group. Until the date of this report, the patient has taken two cycles with three activated drops of MMS, eight times a day, until the sputum culture came out negative. Currently, her only oral treatment is a daily glass of Seawater. Due to the near disappearance of bronchial excretions, she continues with a daily respiratory physiotherapy session, common in France.
